Clinical Trials Directory

Trials / Completed

CompletedNCT04276935

Development of a Health-Related Symptom Index for Participants With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions

Development of a Health-Related Symptom Index for Spanish-Speaking Persons Diagnosed With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (HSIL)

Status
Completed
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
AIDS Malignancy Consortium · Network
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This trial develops a health-related symptom index for participants with and either treated or monitored for anal high-grade squamous intraepithelial lesions. The health-related quality of life index may help to capture the symptoms and related experiences of living with or being treated for high-grade squamous intraepithelial lesions.

Detailed description

PRIMARY OBJECTIVES: I. To develop a Spanish-language version of the anal cancer/high-grade squamous intraepithelial lesions outcomes research (ANCHOR) high-grade squamous intraepithelial lesions (HSIL) health-related quality of life (HRQoL) index (HQI) using state-of-the-art measure development methodology that captures the most important HRQoL symptoms and concerns of those persons diagnosed with anal HSIL and either treated or untreated for anal HSIL. OUTLINE: Participants take part in cognitive interviews in Spanish over 45-60 minutes.

Conditions

Interventions

TypeNameDescription
OTHERInterviewParticipate in cognitive interview
OTHERQuality-of-Life AssessmentAncillary studies
OTHERQuestionnaire AdministrationAncillary studies

Timeline

Start date
2018-11-06
Primary completion
2020-03-01
Completion
2020-03-01
First posted
2020-02-19
Last updated
2025-03-07
Results posted
2023-11-18

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04276935. Inclusion in this directory is not an endorsement.